From strategic partnerships to new community health initiatives and clinical trial announcements, see the latest ways we’re transforming the future of health and research.
The CRESCENDO study, by AstraZeneca, aims to determine the impact of a once-daily pill on easing symptoms, reducing flare-ups, and improving the quality of life for people with COPD.
Read MoreThe AERIFY studies from Sanofi will evaluate if the investigational treatment, itepekimab, reduces dangerous symptom flare-ups in current and former smokers with moderate-to-severe COPD. The study is offered at multiple locations in the U.S.
Read MoreA research study for heart attack and stroke prevention is available to adults 40 to 79 years of age who are at high risk for a first major atherosclerotic cardiovascular disease (ASCVD) event.
Read More 
Care Access announced today the completion of a for-cause Food and Drug Administration ("FDA") Good Clinical Practices ("GCP") inspection related to Care Access's activities on the Pfizer VALOR trial. The inspection resulted in no FDA Form 483 observations...
Read More 
It’s not just about diversity of staff and participants – but also diversity in how clinical research is woven into the fabric of local communities.
Read More